Scott Olson, MD
Neurological Surgery · la Jolla, CANPI 1376568659
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $75,350 of the $104,676 with a category attached, or 72.0%. Microvention, Inc. accounts for 73.3% of it on its own, with 8 other manufacturers making up the rest.
Across 259 payments — averaging $404.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Microvention, Inc.$77K
- Medtronic$27K
- Johnson & Johnson$483
- Stryker$406
- Boston Scientific$140
- Shionogi Inc$34
- plus $68 from 3 others
What the payments were for
- Consulting fees$12,60012%
- Speaking & faculty fees$75,35072%
- Travel & lodging$11,01811%
- Food & beverage$5,7085%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Microvention, Inc. | 148 | $76,693 |
| Medtronic(2 entities) | 70 | $26,852 |
| Johnson & Johnson | 22 | $483 |
| Stryker | 11 | $406 |
| Boston Scientific | 3 | $140 |
| Shionogi Inc | 2 | $34 |
| Neurelis, Inc. | 1 | $27 |
| SK Life Science, Inc. | 1 | $22 |
| Imperative Care, Inc | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- WEB Aneurysm Embolization System$62,465
- Pipeline$24,706
- Azur CX Detachable$290
- CONCERTOTM$158
- STENT$149
- SOFIA 6F-131CM STR$141
- LVIS JUNIOR$141
- WEB$133
- Abre$124
How this compares
$104,676 in reported general payments places this provider in the 85th percentile of 773 neurological surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 12 | $116 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in la Jolla
- Christopher AmesSan Francisco$7.1M
- Larry KhooLos Angeles$2.8M
- Samy AbdouSan Diego$2.4M
- Bret AbshireMurrieta$2.3M
- William TaylorSan Diego$2.1M
- Tooraj GravoriEncino$2M
- Ali MesiwalaRancho Cucamonga$1.5M
- Joseph OsorioSan Diego$1.3M
- Ian JohnsonFresno$1.3M
- Aaron Cohen-GadolLos Angeles$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.